Advances in the diagnosis and treatment of chronic subdural hematoma
10.3969/j.issn.1002-0152.2024.01.006
- VernacularTitle:慢性硬膜下血肿诊治进展
- Author:
Qinjiang HUANG
1
;
Wei HONG
;
Rui LI
;
Wenyong LI
;
Chunyou WAN
;
Shuo LI
;
Jiang DU
Author Information
1. 成都市温江区人民医院神经外科(成都 611130)
- Keywords:
Chronic subdural hematoma;
Atorvastatin;
Drill;
Recurrence;
Embolization
- From:
Chinese Journal of Nervous and Mental Diseases
2024;50(1):33-38
- CountryChina
- Language:Chinese
-
Abstract:
Chronic subdural hematoma is one of the common central nervous system diseases in middle-aged and elderly people,and the incidence is increasing year by year.Drill and drain surgery is recognized as one of the effective ways to treat chronic subdural hematoma.However,there still exists a non-negligible recurrence after surgery.In addition,with the aging of the population,senior patients may have many underlying diseases.Therefore,the risk of surgery is high and some patients even have contraindications to surgery due to the long-term use of anticoagulant or antiplatelet drugs.In recent years,some progress has been made in the treatment of chronic subdural hematoma,such as oral atorvastatin can promote the absorption of chronic subdural hematoma,small-dose dexamethasone is used in the treatment of chronic subdural hematoma,neuroendoscopy-assisted treatment of segregated chronic subdural hematoma,and middle meningeal artery embolization surgery to reduce the recurrence of chronic subdural hematoma patients.Meanwhile,with the development of imaging,Computed Tomography(CT)and Magnetic Resonance Imaging(MRI)have made some progress in the diagnosis of chronic subdural hematoma.
